BMS-986368
- Generic Name
- BMS-986368
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Phase 2
Not yet recruiting
- Conditions
- AgitationAlzheimer Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-05-11
- Lead Sponsor
- Celgene
- Target Recruit Count
- 120
- Registration Number
- NCT06808984
- Locations
- 🇺🇸
Local Institution - 0052, La Jolla, California, United States
🇺🇸Local Institution - 0053, Washington, District of Columbia, United States
🇺🇸Local Institution - 0051, South Dartmouth, Massachusetts, United States
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Phase 2
Not yet recruiting
- Conditions
- Multiple Sclerosis Spasticity
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-01-20
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Celgene
- Target Recruit Count
- 200
- Registration Number
- NCT06782490
- Locations
- 🇩🇪
Local Institution - 0060, Münster, Nordrhein-Westfalen, Germany
🇵🇱Local Institution - 0048, Oswiecim, MA, Poland
🇵🇱Local Institution - 0047, Warszawa, MZ, Poland
A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Participants, Healthy Elderly Participants, and Healthy Participants of Japanese Ethnicity
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2024-11-12
- Lead Sponsor
- Celgene
- Target Recruit Count
- 56
- Registration Number
- NCT06411730
- Locations
- 🇺🇸
Local Institution - 0001, Anaheim, California, United States
A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
Phase 1
Completed
- Conditions
- Healthy Participants
- Interventions
- First Posted Date
- 2023-12-14
- Last Posted Date
- 2024-07-01
- Lead Sponsor
- Celgene
- Target Recruit Count
- 32
- Registration Number
- NCT06170723
- Locations
- 🇺🇸
Local Institution - 0001, Tempe, Arizona, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath